ADVERTISEMENT
Podcasts
Examining Positive Results of Treatment for Patients With Endometrial Cancer
06/29/2020
Sarah Temkin, MD, board-certified gynecologic oncologist, and Don Dizon, MD, oncologist specializing in women’s cancers, discuss an ongoing Phase III trial that examines the use of selinexor for the treatment of endometrial cancer, and highlight what they hope to see for the future of care.
Reference:
Vergote I, Hamilton EP, Romero I, et al. SIENDO/ENGOT-EN5: A randomized phase III trial of maintenance with selinexor/placebo after combination chemotherapy in patients with advanced or recurrent endometrial cancer. J Clin Oncol 38: 2020 (suppl; abstr TPS6105). doi: 10.1200/JCO.2020.38.15_suppl.TPS6105
Advertisement
Advertisement
Advertisement
Current Issue
September 2024
Volume 21
Issue 3
Advertisement
Advertisement
What's Trending?
Subscribe to our eNewsletters!
First Report Managed Care Newsletter